Group 1: Performance Overview - The chemical industry has shown signs of recovery compared to the past two years, with improved operational conditions in Q1 2025 and increased market demand for major products year-on-year [2][3] - The first half of the year is still ongoing, and performance results have yet to be finalized [3] Group 2: Product Development and Capacity - The production of propyl acetate is expected to reach around 800 tons in 2024, with anticipated increases in 2025 as the market for lithium battery electrolytes expands [4] - Revenue from electronic chemicals increased by 110% year-on-year in 2024, with further growth expected in 2025 due to ongoing technical upgrades and an expanding customer base [5] Group 3: Market Trends and Competition - The chemical industry is experiencing a gradual recovery in market demand, particularly as the pesticide sector approaches inventory clearance, leading to increased demand for major products [5][6] - Despite the overall increase in demand, the competitive landscape remains intense, with varying supply and demand dynamics across different products [6] Group 4: Future Plans and Financing - The company is focused on advancing its fundraising projects and has not disclosed any plans for refinancing or stock incentive programs at this time [6]

Group 1 - The company has approved a cash dividend distribution plan for the fiscal year 2024, with a total distribution of 12 million RMB (before tax) to shareholders [1][2] - The distribution is set at 1.20 RMB per 10 shares, based on a total share capital of 108 million shares as of April 23, 2025 [1][2] - The dividend will not include stock bonuses or capital reserve transfers, with any undistributed profits carried forward to the next fiscal year [1] Group 2 - The record date for the dividend distribution is June 11, 2025, and the ex-dividend date is June 12, 2025 [2] - The distribution will be directly credited to shareholders' accounts through their securities companies or other custodians [2] - The company assumes all legal responsibilities for any issues arising from insufficient cash dividends due to a decrease in shareholders' securities [2] Group 3 - The company has made commitments regarding the minimum selling price of shares held by shareholders after the lock-up period, which will be adjusted to not less than 28.767 RMB per share following the dividend distribution [2]

证券代码：301212 证券简称：联盛化学 公告编号：2025-028 浙江联盛化学股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江联盛化学股份有限公司（以下简称"公司"或"本公司"）2024 年年度 权益分派方案已获 2025 年 5 月 15 日召开的 2024 年年度股东大会审议通过，现 将权益分派事宜公告如下： 一、股东大会审议通过权益分派方案情况 1、公司于 2025 年 5 月 15 日召开 2024 年年度股东大会，审议通过了《关于 公司<2024 年度利润分配预案>的议案》，具体方案如下：公司以截至 2025 年 4 月 23 日的总股本 108,000,000 股为基数，向全体股东每 10 股派发现金红利 1.20 元（含税），合计派发 1,296 万元（含税）。本次利润分配不送红股，不以公积 金转增股本，剩余未分配利润结转至下一年度。 2、自权益分派方案披露之日起至实施期间，公司股本总额未发生变化。 3、本次实施的权益分派方案与 2024 年年度股东大会审议通过的权益分派方 案一致。 4、 ...

Group 1: Financial Performance - In 2024, the company's revenue decreased by 4.47%, and the net profit attributable to shareholders dropped significantly by 75.73% due to a larger decline in product sales prices compared to raw material prices, resulting in a substantial decrease in gross margin [3] - The company reported that the net profit decline was primarily driven by the significant drop in sales prices [3] Group 2: Research and Development - The company emphasizes R&D as a key driver for development, focusing on high-value products in electronic chemicals, specialty new materials, and pharmaceutical intermediates [3] - R&D investment as a percentage of total revenue has remained stable over the past three years [3] Group 3: Market and Product Development - The company is currently constructing new projects for ultra-pure electronic chemicals and biodegradable new materials, with specific capacity and expected revenue detailed in the 2024 annual report [4] - In the first quarter, some products saw a year-on-year increase in overseas demand, with electronic chemicals revenue increasing by over 110% [4] Group 4: Environmental Compliance - The company invested 6.73 million yuan in environmental protection and successfully passed the B-level rating for air pollution prevention and control performance [4] - The company adheres to national environmental laws and regulations, ensuring compliance with the latest environmental policies [4] Group 5: Customer Base and Market Positioning - The company's main clients include well-known large enterprises such as Bayer Group and Lawrence Research [4] - The company is focusing on differentiated competition by understanding market needs and providing customized solutions [4] Group 6: Sustainability Initiatives - The company is committed to green, low-carbon, and digital transformation, enhancing technology innovation and process optimization [5] - Efforts include energy-saving and emission-reduction actions, integrating low-carbon training into daily operations to support sustainable development [5]

证券代码：301212 证券简称：联盛化学 公告编号：2025-027 2024 年年度股东大会决议公告 1、召开时间：2025 年 5 月 15 日（星期四）14:30 2、召开地点：浙江省临海市头门港经济开发区东海第三大道9号公司会议室 3、召开方式:本次股东大会采用现场投票与网络投票表决相结合的方式召开 浙江联盛化学股份有限公司 4、召集人：浙江联盛化学股份有限公司（以下简称"公司"）董事会 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会不存在否决议案的情形。 参加本次股东大会现场会议和网络投票表决的股东及股东代理人共 48 人， 代表有表决权的股份合计为 81,139,300 股，占公司有表决权股份总数 108,000,000 股的 75.1290％。其中：通过现场投票的股东共 5 人，代表有表决 权的公司股份数合计为 81,000,400 股，占公司有表决权股份总数 108,000,000 股的 75.0004%；通过网络投票的股东共 43 人 ...

国浩律师（杭州）事务所 关于 浙江联盛化学股份有限公司 2024 年年度股东大会 法律意见书 地址：杭州市上城区老复兴路白塔公园 B 区 2 号、15 号国浩律师楼 邮编：310008 Grandall Building, No.2＆No.15, Block B, Baita Park, Old Fuxing Road, Hangzhou, Zhejiang 310008, China 电话/Tel: (+86)(571) 8577 5888 传真/Fax: (+86)(571) 8577 5643 电子邮箱/Mail：grandallhz@grandall.com.cn 网址/Website：http://www.grandall.com.cn 二〇二五年五月 国浩律师（杭州）事务所 法律意见书 国浩律师（杭州）事务所 关于浙江联盛化学股份有限公司 2024 年年度股东大会 法律意见书 致：浙江联盛化学股份有限公司 国浩律师（杭州）事务所（以下简称"本所"）接受浙江联盛化学股份有限 公司（以下简称"公司"）委托，指派律师出席公司 2024 年年度股东大会（以下 简称"本次股东大会"），并依据《中华人民共和国 ...

证券代码：301212 证券简称：联盛化学 公告编号：2025-026 浙江联盛化学股份有限公司 关于举办2024年度暨2025年第一季度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示： 浙江联盛化学股份有限公司（以下简称"公司"）已于 2025 年 04 月 25 日 在深圳证券交易所网站（www.szse.cn）及巨潮资讯网(www.cninfo.com.cn)上披 露了《浙江联盛化学股份有限公司 2024 年年度报告》《浙江联盛化学股份有限 公司 2024 年年度报告摘要》及《浙江联盛化学股份有限公司 2025 年第一季度报 告》。为便于广大投资者更加全面深入地了解公司经营业绩、发展战略等情况， 公司定于 2025 年 05 月 16 日（星期五）15:00-16:00 在"价值在线"（www.ir- online.cn）举办浙江联盛化学股份有限公司 2024 年度暨 2025 年第一季度业绩 会议召开时间：2025 年 05 月 16 日（星期五）15:00-16:00 会议召开方式：网络互动方式 会议召开地点：价值在线 ...

Group 1: Financial Performance - In Q1 2025, the company experienced a significant increase in revenue and net profit due to a recovery in demand within the chemical industry, with a notable rise in sales volume of key products [2] - The BDO industry chain products saw an increase in capacity utilization compared to the same period last year, reflecting improved customer order performance [3] Group 2: Product and Market Position - ABL, the company's flagship product, has a large production scale and high quality, with its production technology recognized as internationally advanced, making it the first in China to utilize liquid sodium for continuous reaction [4] - The demand for ABL is expected to rise following the expiration of the patent for the broad-spectrum fungicide, but the supply side remains competitive with low product prices [4] Group 3: Future Development and Investments - The company has over 500 million RMB in ongoing construction projects, primarily focused on ultra-pure electronic chemicals and biodegradable new materials [4] - As of December 31, 2024, the company employed 411 people and has plans for potential employee stock ownership programs in the future [4] Group 4: Industry Outlook - The fine chemical industry is a strategic focus for global chemical development, with the company emphasizing green, low-carbon, and digital transformation [5] - The company aims to enhance its position in the fine chemical sector by advancing its three main business areas: fine chemicals, electronic chemicals, and biodegradable new materials, supported by 51 invention patents as of the end of 2024 [5]

Financial Performance - The company reported a basic earnings per share of 0.1600 yuan for 2024, a decrease of 75.76% compared to 0.6600 yuan in 2023 [1] - Net profit for 2024 was 0.17 billion yuan, down 76.06% from 0.71 billion yuan in the previous year [1] - Operating revenue decreased by 4.53% to 6.32 billion yuan in 2024 from 6.62 billion yuan in 2023 [1] - The return on equity (ROE) fell to 1.29% in 2024, a significant drop of 75.98% from 5.37% in 2023 [1] Shareholder Information - The top ten unrestricted shareholders collectively hold 3.5199 million shares, accounting for 13.04% of the circulating shares, with an increase of 328,900 shares compared to the previous period [1] - Notable changes among the top shareholders include an increase of 244,700 shares held by Hong Ping and new entries by Zhang Qinhua, Zeng Hua, and Tao Hongge [2] Dividend Distribution - The company announced a dividend distribution plan of 1.2 yuan per share (including tax) [3]

证券代码：301212 证券简称：联盛化学 公告编号：2025-025 浙江联盛化学股份有限公司 关于召开 2024 年年度股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江联盛化学股份有限公司（以下简称"公司"或"本公司"）于 2025 年 4 月 23 日召开第四届董事会第二次会议审议通过了《关于召开 2024 年年度股东 大会的议案》，根据《中华人民共和国公司法》《中华人民共和国证券法》《深 圳证券交易所创业板股票上市规则》等有关法律法规及《公司章程》的相关规定， 公司董事会决定于 2025 年 5 月 15 日召开 2024 年年度股东大会，现将有关事项 通知如下： 一、会议召开的基本情况 1、股东大会届次：2024 年年度股东大会 2、召集人：浙江联盛化学股份有限公司董事会 3、合法、合规性：本次股东大会的召集及召开符合相关法律、行政法规、 部门规章、规范性文件、深圳证券交易所相关规则以及《公司章程》的有关规定。 4、会议召开日期、时间： （1）现场会议时间：2025 年 5 月 15 日下午 14:30 开始 （2）网络投票时间： ...